Chief medical officer warns against use of weight-loss drugs

Chris Whitty IGD conf 2025

Chris Whitty said the lack of data about the booming GLP-1 category of drugs meant they should only be prioritised as a solution for people with morbid obesity problems

Chief medical officer Chris Whitty has warned the government against a mass shift to the use of weight-loss drugs to tackle the obesity crisis, saying there is a lack of long-term evidence over their safety and effectiveness.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW